Pressure BioSciences, Inc. (PBI), a life sciences company, engages in the research, development, and commercialization of sample preparation system. It focuses on the development of a platform technology, called pressure cycling technology (PCT) that uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. The company offers Barocycler instrument and an internally developed disposable PULSE (Pressure Used to Lyse Samples for Extraction) Tubes, which together make up the PCT sample preparation system. It holds 13 U.S. and 5 foreign patents covering multiple applications of PCT in the life sciences field. PCT has applications in a various life sciences areas, including sample preparation for genomic, proteomic, and small molecule studies; control of chemical (enzymatic) reactions; protein purification; pathogen inactivation; immunodiagnostics; DNA sequencing; and food safety. PBI's customers include academic laboratories, government agencies, and biotechnology companies. The company was founded in 1978. It was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in 2004. Pressure BioSciences is based in South Easton, Massachusetts.
Uncle Bud's is a provider of Hemp and CBD health & wellness products.
CannaWorx
Acquisition in 2020
CannaWorx is a company operating in the rapidly growing cannabis industry, focusing on providing sustainable health and wellness solutions through the use of cannabis. With the momentum for legalization of marijuana gaining strength in the United States and beyond, CannaWorx aims to utilize the medicinal properties of the hemp/cannabis plant to offer benefits to individuals seeking alternative health options. By embracing the natural gift of cannabis and promoting its various uses beyond recreational purposes, CannaWorx is positioned to contribute to the evolving landscape of cannabis as a mainstream health and wellness solution.
BaroFold
Acquisition in 2017
BaroFold is a biopharmaceutical company dedicated to the development of innovative protein therapeutics, particularly targeting immunology conditions such as Multiple Sclerosis, Rheumatoid Arthritis, and Asthma. The company utilizes its proprietary PreEMT™ technology, which employs high pressure folding to enhance the tolerability, efficacy, and safety of protein biologics. This technology allows for the disaggregation and controlled refolding of proteins, ensuring a high fidelity of native structure. By leveraging this state-of-the-art approach, BaroFold aims to support biopharmaceutical companies, research institutions, and government agencies in creating novel therapeutics, accelerating development processes, and managing the life cycles of protein-based treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.